Form 4 for STE Steris
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-059531 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-01 | STE | Madsen Julia | Senior VP, Life Sciences | A - Grant | $0.00 | +576 | 6,433 | +10% | $0 |
| D | 2021-10-05 | 2021-10-01 | STE | Madsen Julia | Senior VP, Life Sciences | D - Sale to Iss | $228.36 | -121 | 6,312 | -2% | -$27.6K |
| D | 2021-10-05 | 2021-10-01 | STE | Madsen Julia | Senior VP, Life Sciences | A - Grant | $0.00 | +3,152 | 3,152 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-10-01 | A | A | 576 | $0.00 | 6,433 | D | — | — | (F1) All 576 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 3, 2022; 144 on October 2, 2023; 144 on October 1, 2024 and 144 on October 1, 2025. (F2) 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. |
| 2 | Common | Ordinary Shares | 2021-10-01 | D | D | 121 | $228.36 | 6,312 | D | — | — | (F3) 121 shares were withheld from the 349 restricted shares that vested on October 1, 2021. These 121 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 349 restricted shares were part of an award of 1,396 ordinary shares that were awarded to Ms. Madsen on October 1, 2020. These vested shares were valued at the NYSE closing market price on October 1, 2021. (F2) 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-10-01 | A | A | 3,152 | $0.00 | 3,152 | D | $228.36 · — to 2031-10-01 | 3,152 Ordinary Shares | (F4) This option becomes exercisable as follows: 788 on October 3, 2022; 788 on October 2, 2023; 788 on October 1, 2024 and 788 on October 1, 2025. |